(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 5.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.56%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.43%.
Bruker's revenue in 2025 is $3,366,400,000.On average, 5 Wall Street analysts forecast BRKR's revenue for 2025 to be $528,995,010,585, with the lowest BRKR revenue forecast at $524,247,549,058, and the highest BRKR revenue forecast at $533,880,827,226. On average, 5 Wall Street analysts forecast BRKR's revenue for 2026 to be $562,844,984,721, with the lowest BRKR revenue forecast at $553,314,259,246, and the highest BRKR revenue forecast at $572,128,734,182.
In 2027, BRKR is forecast to generate $602,799,878,227 in revenue, with the lowest revenue forecast at $588,145,765,819 and the highest revenue forecast at $616,616,274,698.